Comparative Assessment of VTE and Other Risks among Patients with Rheumatoid Arthritis treated with Baricitinib versus Tumor Necrosis Factor Inhibitors: A Multi-database Observational Cohort Study

17/12/2020
23/04/2024
EU PAS number:
EUPAS32271
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B023 05 Protocol(d)

English (856.46 KB - PDF) View document
Study results
Study results

Non interventional PASS B023 Final Study Report_Redacted_Part 1 of 6

English (2.11 MB - PDF) View document
Study report
Study report

Non interventional PASS B023 Final Study Report_Redacted_Part 2 of 6

English (9.51 MB - PDF) View document

Non interventional PASS B023 Final Study Report_Redacted_Part 3 of 6

English (6.11 MB - PDF) View document

Non interventional PASS B023 Final Study Report_Redacted_Part 4 of 6

English (9.5 MB - PDF) View document

Non interventional PASS B023 Final Study Report_Redacted_Part 5 of 6

English (9.5 MB - PDF) View document

Non interventional PASS B023 Final Study Report_Redacted_Part 6 of 6

English (4.27 MB - PDF) View document
Other information
Study, other information

Non interventional PASS B023 Final Study Report_Redacted_Part 6 of 6.pdf

English (4.27 MB - PDF) View document

Non interventional PASS B023 Final Study Report_Redacted_Part 5 of 6.pdf

English (9.5 MB - PDF) View document

Non interventional PASS B023 Final Study Report_Redacted_Part 4 of 6.pdf

English (9.5 MB - PDF) View document

Non interventional PASS B023 Final Study Report_Redacted_Part 3 of 6.pdf

English (6.11 MB - PDF) View document